The androgen receptor CAG repeat polymorphism and risk of breast cancer in the nurses’ health study

Cancer Research

Volumn 62, Issue 4, 2002, Pages 1045-1049

  Haiman, Christopher A ^a,b,e   Hankinson, Susan E ^a,c   Spiegelman, Donna ^a   Colditz, Graham A ^a,b,c   Willett, Walter C ^a,b,c   Hunter, David J ^a,b,c   Kantoff, Philip W ^d   Brown, Myles ^d  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD CENTER FOR CANCER PREVENTION   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036168101     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Interactions between estradiol and progesterone in normal breast
2. Endogenous hormones and breast cancer risk
3. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
4. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk
5. A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey
6. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
7. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in post-menopausal women
8. Relationship of serum DHEA, DHEAS and 5-androstene-3β, 17β-diol to risk of breast cancer in postmenopausal women
9. Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer
10. Adrenal androgens and human breast cancer: A new appraisal
11. Adrenal androgens stimulate the proliferation of breast cancer cells as direct activators of estrogen receptor α
12. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation
13. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
14. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
15. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor
16. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
17. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
18. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility
19. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
20. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers
21. Lack of an association between androgen receptor CAG polymorphism and familial breast/ovarian cancer
22. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population
23. Androgen receptor exon I CAG repeat length and breast cancer in women before age forty years
24. No association between androgen receptor or vitamin D receptor gene polymorphism and risk of breast cancer
25. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period
26. Increased availability of serum estrogens in breast cancer: A new hypothesis
27. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
28. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men
29. Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women